Table 1 Baseline clinical characteristics of non-DM and T2DM HD patients before HD session
All HD patients (n = 49) | Non-DM group (n = 24) | T2DM group (n = 25) | P value | |
|---|---|---|---|---|
Age, years | 66.7 ± 11.5 | 68.6 ± 11.3 | 64.8 ± 11.6 | 0.2220 |
Gender, male/female | 32/17 | 13/11 | 19/6 | 0.1085 |
BMI, kg/m2 | 22.7 ± 4.5 | 21.3 ± 4.3 | 24.0 ± 4.3 | 0.0494* |
HD duration, years | 4.5 (2.5–6.3) | 4.7 (3.4–7.1) | 4.3 (2.2–5.5) | 0.1497 |
Interdialytic BW gain, % | 5.3 (4.3–5.9) | 5.4 (4.5–6.9) | 5.2 (4.1–5.6) | 0.2041 |
Serum urea nitrogen, mg/dL | 60.5 ± 16.1 | 64.4 ± 18.3 | 56.8 ± 12.5 | 0.1096 |
Cre, mg/dL | 10.0 ± 2.8 | 10.0 ± 2.7 | 10.1 ± 2.8 | 0.9045 |
Alb, g/dL | 3.6 (3.4–3.8) | 3.5 (3.2–3.7) | 3.7 (3.5–3.9) | 0.0141* |
Fasting plasma glucose, mg/dL | 122.0 (101.8–152.3) | 115.5 (93.0–134.0) | 145.0 (117.8–163.8) | 0.0117* |
Glycoalbumin, % | 16.8 ± 3.0 | 15.2 ± 2.2 | 18.2 ± 3.0 | 0.0003* |
CRP, mg/dL | 0.11 (0.04–0.34) | 0.11 (0.03–0.33) | 0.11 (0.04–0.35) | 0.6237 |
LDL-C, mg/dL | 78.9 (56.3–102.0) | 83.0 (58.5–107.0) | 75.0 (51.8–95.8) | 0.3127 |
Uric acid, mg/dL | 5.9 (5.3–7.0) | 6.2 (5.3–7.1) | 5.8 (5.0–6.8) | 0.3023 |
cCa, mg/dL | 8.4 ± 0.6 | 8.5 ± 0.6 | 8.4 ± 0.6 | 0.6378 |
Pi, mg/dL | 5.5 (4.9–6.1) | 5.6 (4.9–6.1) | 5.5 (4.8–6.2) | 0.9920 |
Arterial blood | ||||
pH | 7.34 (7.32–7.36) | 7.34 (7.31–7.36) | 7.34 (7.33–7.36) | 0.5754 |
HCO3, mEq/L | 19.9 ± 2.2 | 19.4 ± 2.6 | 20.4 ± 1.7 | 0.2844 |
AcAc, μmol/L | 26.0 (21.8–43.3) | 26.0 (20.0–36.5) | 28.0 (22.0–49.3) | 0.3839 |
β-HB, μmol/L | 20.0 (14.8–42.0) | 17.0 (11.5–36.0) | 29.0 (17.0–59.5) | 0.0134* |
AcAc/ β-HB ratio, μmol/μmol | 1.18 (0.76–1.51) | 1.35 (1.06–2.17) | 0.91 (0.73–1.24) | 0.0155* |